IL6 and metabolic dysfunction-associated steatotic liver disease: Moreover, MASLD is associated with increased levels of plasma leptin, which in turn promotes the release of pro-inflammatory cytokines such as tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6), thereby contributing to sterile inflammation [19,20,21].